7+3

• Mitoxantrone
• Daunorubicin Hydrochloride
• Idarubicin
• Cytarabine

Name

Mitoxantrone

Alternate Names

CL 232315

Mitoxantrone Hydrochloride

Mitozantrone

Novantrone

Abbreviations

DAD

DHAD

DHAQ

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

301739

Primary Site

Acute myelogenous leukemia (AML)

Breast

Non-Hodgkin lymphoma

Prostate- advanced hormone-refractory

Histology

None

Remarks

Antibiotic-class antineoplastic. FDA approved uses in adult acute non-lymphocytic leukemia, and prostate cancer pain reduction in combination with prednisone. Novantrone is a synthetic antineoplastic anthracenedione

Coding

This drug should be coded

Name

Daunorubicin Hydrochloride

Alternate Names

Acetyladriamycin

Cerubidine

Dauno-blastin

Daunomycin

Daunomycin-HCl

Daunorubicin

Daunorubicine

FI-6339

Leuk-aemomycin C

NDC-0082-4155

RP-13057

Rubidomycin

Rubidomycin HCl

Rubomycin C

Abbreviations

Daun

Dauno

DNM

DNR

DRB

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

082151

82151

Primary Site

Leukemia

Histology

None

Remarks

FDA approved use on ALL and ANLL; antitumor antibiotic

Coding

This drug should be coded

Name

Idarubicin

Alternate Names

4-Demethoxydaunorubicin

Idamycin

Idamycin PFS

Idarubicin hydrochloride

IMI 30

IMI-30

SC-33428

Abbreviations

4-DMDR

IDA

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

256439

Primary Site

Acute lymphoblastic leukemia (ALL)

Acute myelogenous leukemia (AML)

Chronic myelogenous leukemia in blast crises

Myelodysplastic syndromes (MDS)

Histology

None

Remarks

An anthracycline antineoplastic agent. FDA approved uses on acute lymphocytic and non-lymphcytic leukemia.

Coding

This drug should be coded

Name

Cytarabine

Alternate Names

AC-1075

Alexan

Ara-cytidine

Arabinocytidine

Arabinosylcytosine

Beta-Arabinosylcytosine

Cytarabin

Cytarabine

Cytarabinoside

Cytosar

Cytosar-U

Cytosine Arabinoside

Cytosine arabinoside hydrochloride

Spongocytidine HCL

Tarabine

Tarabine PFS

U-19920

U-19920A

WR-28453

Abbreviations

ara-C

CA

HDA

HDARA-C

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

063878

63878

Primary Site

ALL

AML

CML

head and neck

Hodgkin's disease

leukemia

Meningeal leukemia

NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded